Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.
about
Control of Body Weight by Eating Behavior in ChildrenCan We Selectively Reduce Appetite for Energy-Dense Foods? An Overview of Pharmacological Strategies for Modification of Food Preference BehaviorTreatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss.Identification and characterization of metformin on peptidomic profiling in human visceral adipocytes.Liraglutide: a review of its use in the management of obesity.Liraglutide for Type 2 diabetes and obesity: a 2015 update.Functional foods as potential therapeutic options for metabolic syndrome.Efficacy and safety of once-weekly semaglutide for the treatment of type 2 diabetes.Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetes.The incretin system ABCs in obesity and diabetes - novel therapeutic strategies for weight loss and beyond.Liraglutide Promotes Cortical Neurite Outgrowth via the MEK-ERK Pathway.Preproglucagon neurons in the hindbrain have IL-6 receptor-α and show Ca2+ influx in response to IL-6.2014 EASO Position Statement on the Use of Anti-Obesity Drugs.Functional interleukin-6 receptor-α is located in tanycytes at the base of the third ventricle.Weight loss and weight maintenance obtained with or without GLP-1 analogue treatment decrease branched chain amino acid levels
P2860
Q26779285-AFADDDAA-93B4-4B6A-8EC4-DB40B3F3B072Q34501087-4BEB9320-D0C3-46B9-8AF7-0E6D68775D08Q34665186-72D9FCFA-96BF-41AD-9F7C-43263AB480B5Q38429955-978D1057-A6B6-436F-B8D7-3EDEC5D34B1DQ38488650-C22C760F-042C-4A92-ABF6-B049DCAA9B81Q38536672-305DD6AB-867B-4537-9647-F078CBEE1AECQ38582214-8EA79E66-9C09-418F-A187-B081F15537E0Q38662690-536335E0-8932-4B6C-90DC-5C788ED6E123Q38708352-01B99BF6-1FB8-49C8-A679-0CD4429077A2Q38820260-8B710033-34DC-4D87-9098-B2478895BF6FQ41090019-B580CACE-2E6B-417E-A285-DBC1F73F47F3Q42011586-7DCBA3C1-2EDC-4937-8979-5A3A33177150Q47129264-C918BBE2-8B5F-41AD-810F-347E8EA6E8D0Q48200213-86130167-5B99-43BC-88CD-18376575B63BQ57655866-B0B7A556-2056-47CC-A102-9668B881A9CC
P2860
Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.
@en
type
label
Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.
@en
prefLabel
Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.
@en
P2860
P50
P1476
Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.
@en
P2860
P304
P356
10.1517/14656566.2014.965678
P407
P577
2014-09-26T00:00:00Z